Company lists · Data refreshed September 2026

Top 21 Rare disease gene therapy companies based in France

RevenueBase identified 37 rare disease gene therapy companies headquartered in France as of September 2026 and tracks 1,145 professional contacts across them, including 433 with verified work emails. Paris is the largest hub.

This list covers rare disease gene therapy companies headquartered in France, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 21, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 21, 2026 86% judged on-target in blind review
37Companies
1,145Contacts tracked
433Verified emails
Explore this list → Free signup · no credit card · 500 free credits

The 21 largest rare disease gene therapy companies based in France

Ranked by team size
Top 21 of 37 rare disease gene therapy companies based in France, ranked by team size, largest first. Data refreshed Sep 21, 2026. RevenueBase Smart Search rates how each company's information relates to rare disease gene therapy companies: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#CompanyRevenueBase Smart SearchHeadquartersEmployeesContacts
1Indirect evidenceÉvry, FranceHQ checked Sep 21, 2026201-500293 contacts →

Indirect evidence

“Généthon est un laboratoire à but non lucratif, créé et soutenu par l’AFM-Téléthon depuis 1990.”

Source: RevenueBase Database · checked Sep 21, 2026
2Strong evidenceParis, FranceHQ checked Sep 21, 202651-200118 contacts →

Strong evidence

“Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful…”

Source: RevenueBase Database · checked Sep 21, 2026
3Indirect evidenceParis, FranceHQ checked Sep 21, 202611-5045 contacts →

Indirect evidence

“SparingVision is a genomic medicines company, translating pioneering science into vision-saving treatments.”

Source: RevenueBase Database · checked Sep 21, 2026
4Strong evidenceParis, FranceHQ checked Sep 21, 2026n/a42 contacts →

Strong evidence

“Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.”

Source: RevenueBase Database · checked Sep 21, 2026
5Indirect evidenceNantes, FranceHQ checked Sep 21, 202651-20041 contacts →

Indirect evidence

“Laboratoire de Thérapie génique de Nantes”

Source: RevenueBase Database · checked Sep 21, 2026
6Partial evidenceLille, FranceHQ checked Sep 21, 202611-5031 contacts →

Partial evidence

“Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs.”

Source: RevenueBase Database · checked Sep 21, 2026
7Strong evidenceParis, FranceHQ checked Sep 21, 202611-5030 contacts →

Strong evidence

“GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous…”

Source: RevenueBase Database · checked Sep 21, 2026
8Partial evidenceValbonne, FranceHQ checked Sep 21, 2026201-50028 contacts →

Partial evidence

“Sangamo Therapeutics France is the French subsidiary of Sangamo Therapeutics Inc.”

Source: RevenueBase Database · checked Sep 21, 2026
9Strong evidenceParis, FranceHQ checked Sep 21, 202611-5014 contacts →

Strong evidence

“Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases.”

Source: RevenueBase Database · checked Sep 21, 2026
10Indirect evidenceParis, FranceHQ checked Sep 21, 2026n/a13 contacts →

Indirect evidence

“Installé au sein d’un bâtiment dédié à la recherche à l’hôpital Saint-Louis AP-HP, le Centre MEARY de Thérapie Cellulaire et Génique de l’AP-HP a pour vocation la production et la…”

Source: RevenueBase Database · checked Sep 21, 2026
11Indirect evidenceParis, FranceHQ checked Sep 21, 202611-5010 contacts →

Indirect evidence

“Mise au point en Immunologie et Cancérologie de médicaments innovants à potentiel curatif.”

Source: RevenueBase Database · checked Sep 21, 2026
12Strong evidenceParis, FranceHQ checked Sep 21, 202611-509 contacts →

Strong evidence

“PulseSight is an ophthalmology drug development company developing disruptive non-viral gene therapies with minimally-invasive delivery technology to treat major eye diseases.”

Source: RevenueBase Database · checked Sep 21, 2026
13Partial evidenceBalma, FranceHQ checked Sep 21, 20261-109 contacts →

Partial evidence

“ABIONYX Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment.”

Source: RevenueBase Database · checked Sep 21, 2026
14Strong evidenceSophia Antipolis, FranceHQ checked Sep 21, 20261-108 contacts →

Strong evidence

“Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases.”

Source: RevenueBase Database · checked Sep 21, 2026
15Partial evidenceMarseille, FranceHQ checked Sep 21, 20261-108 contacts →

Partial evidence

“Développement de médicaments pour le traitement de maladies génétiques rares avec vieillissement prématuré ou accéléré”

Source: RevenueBase Database · checked Sep 21, 2026
16Strong evidenceLa Ciotat, FranceHQ checked Sep 21, 20261-105 contacts →

Strong evidence

“We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials.”

Source: RevenueBase Database · checked Sep 21, 2026
17Indirect evidenceParis, FranceHQ checked Sep 21, 20261-103 contacts →

Indirect evidence

“Variant is a biotechnology company that develops innovative products in the ophthalmology sector.”

Source: RevenueBase Database · checked Sep 21, 2026
18Partial evidenceLyon, FranceHQ checked Sep 21, 202611-502 contacts →

Partial evidence

Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA).”

Source: RevenueBase Database · checked Sep 21, 2026
19Indirect evidenceBoulogne-Billancourt, FranceHQ checked Sep 21, 202611-502 contacts →

Indirect evidence

“CTRS is a French pharmaceutical company with a strong and growing international presence.”

Source: RevenueBase Database · checked Sep 21, 2026
20Strong evidenceParis, FranceHQ checked Sep 21, 20261-101 contacts →

Strong evidence

“BrainVectis' aim is to develop gene therapy treatments for neurodegenerative diseases by targeting the cholesterol pathway in the brain.”

Source: RevenueBase Database · checked Sep 21, 2026
21Strong evidenceEvry, FranceHQ checked Sep 21, 20261-101 contacts →

Strong evidence

“Atamyo Therapeutics is focused on the development of a new generation of safe and effective gene therapies for neuromuscular diseases.”

Source: RevenueBase Database · checked Sep 21, 2026

Showing 21 of 37 rare disease gene therapy companies based in France

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 433 reachable decision-makers.

Free signup · no credit card

View the full list →

Rare disease gene therapy companies based in France at a glance

As of Sep 21, 2026
37.8%Verified-email coverage
30.9Average contacts per company
11-50Median size (employees)
35.1%Largest-city concentration · Paris
Sep 21, 2026Page data refreshed

Companies by employee count

1-10
15
11-50
13
51-200
4
201-500
3
501-1,000
1
5,001-10,000
1

Email recency for this list is measured worldwide rather than for France, so it is reported there. Company counts and contact totals on this page are exact for France, over 37 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among rare disease gene therapy companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source
The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies
Companies headquartered in France whose own description of what they do matches “rare disease gene therapy companies”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search
RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names rare disease gene therapy companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude
Companies whose own description does not clearly place them among rare disease gene therapy companies, and records with no verified work email. Companies headquartered outside France are excluded even when they keep an office there.
Match quality
In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking
Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification
Every listed company carries at least one verified work email, 433 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh
This page's figures were pulled from the company graph on September 21, 2026. Lists refresh periodically as the graph is re-checked.
Corrections
Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names rare disease gene therapy companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many rare disease gene therapy companies are there based in France?

RevenueBase identified 37 rare disease gene therapy companies headquartered in France as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Genethon, headquartered in Evry, tops this list with the largest team on record.

Which city has the most rare disease gene therapy companies?

Paris leads with 13 headquartered companies, followed by Lyon (4) and Evry (3).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 433 verified decision-maker contacts tracked across these 37 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 21, 2026.

Ready to reach these companies? Verified emails and direct dials for all 37 rare disease gene therapy companies based in France. Start with a free account, no credit card.

Download this list →

Related lists

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.